Molly A. Nelson

1 ta ish

PDX Pharmaceuticals (United States)

1. In Situ Tumor Vaccination with Nanoparticle Co‐Delivering CpG and STAT3 siRNA to Effectively Induce Whole‐Body Antitumor Immune Response

   Worapol Ngamcherdtrakul, Moataz Reda, Molly A. Nelson +11

   MaqolaOAOchiq kirish20212 iqtibos

   ABIABI:AkademIndex/2026.other.121410